Global Neuropathic Pain Market Forecasted to Grow at CAGR of 6.8% Through 2034 | Leading Players Include Pfizer & Sanofi
The global neuropathic pain market is poised for significant growth, valued at USD 6,316.6 million in 2024 and projected to reach USD 14,538.7 million by 2034, reflecting a compound annual growth rate (CAGR) of 5.7% over the forecast period. This expansion is driven by the rising prevalence of chronic conditions such as diabetes and cancer, an aging global population, and advancements in...
0 Commentaires 0 Parts 99 Vue